Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
covid-19_vaccines:lipid_nanoparticle [2022/03/08 21:40]
liam [Patents]
covid-19_vaccines:lipid_nanoparticle [2022/11/24 19:45] (current)
liam [Intellectual Property and Patents]
Line 13: Line 13:
 ===== Intellectual Property and Patents ===== ===== Intellectual Property and Patents =====
  
-The ownership and licensure of the LNP technology underlying the [[:mRNA]] [[:COVID-19 vaccines]] is controversial.+The ownership and licensure of the LNP technology underlying the [[:mRNA]] [[:COVID-19 vaccines]] is controversial. See the below graphic from //Patent network analysis of mRNA-based vaccine candidates for COVID-19//:((Gaviria, M., & Kilic, B. (2021). //A network analysis of COVID-19 mRNA vaccine patents.// Nature Biotechnology, 39(5), 546–548. https://doi.org/10.1038/s41587-021-00912-9)) 
 + 
 +{{:covid-19_vaccines:41587_2021_912_fig1_html_copy.jpg?600 |}}
  
 ==== Patents ==== ==== Patents ====
Back to top